Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Antibiotic Development to Advance Patient Treatment Act
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Funding for the Centers for Disease Control and Prevention programs, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539
Antibiotic Development to Advance Patient Treatment Act
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Funding for CDC core programs, Antibiotic Resistance, National Healthcare Safety Network Zika Virus
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Funding for the Centers for Disease Control and Prevention programs, Conditions of Participation for End-Stage Renal Disease facilities, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics,
Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Funding for the Centers for Disease Control and Prevention programs, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539
21st Century Cures Act
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Funding for the Centers for Disease Control and Prevention programs, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539
21st Century Cures Act
Client: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY · Firm: ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY
Funding for the Centers for Disease Control and Prevention programs, Conditions of Participation for End-Stage Renal Disease facilities, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics,
Funding for the Centers for Disease Control and Prevention programs, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics, the Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act, H.R. 3539
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for the Centers for Disease Control and Prevention programs, Conditions of Participation for End-Stage Renal Disease facilities, H.R. 6 - the 21st Century Cures Act and provisions related to antibiotic development and reimbursement, H.R. 2629 - Antibiotic Development to Advance Patient Treatment (ADAPT) Act: Creation of a new regulatory pathway for certain antibiotics,
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Funding for the Centers for Disease Control and Prevention programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for CDC's National Healthcare Safety Network (NHSN), Support for antibiotic resistance initiatives
Filing targets: HOUSE OF REPRESENTATIVES
Support for funding the Centers for Disease Control and Prevention and the National Healthcare Safety Network, Prevention Epicenters, and the Detect and Protect Against Antibiotic Resistance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Support for funding the Centers for Disease Control and Prevention and the National Healthcare Safety Network, Prevention Epicenters, and the Detect and Protect Against Antibiotic Resistance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE